Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Inghirami

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Science Translational Medicine|September 27, 2019
CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignanciesHong Qin, Zhenyuan Dong, Xiuli Wang, et al.
Cancer Cell|May 3, 2024
Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomasJaewoo Choi, Michele Ceribelli, James D Phelan, et al.
Blood Cancer Journal|November 10, 2018
Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trialsA Castellino, A Chiappella, B R LaPlant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2011
Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletionM Mian, M Scandurra, E Chigrinova, et al.
Leukemia|August 23, 2018
Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphomaNicole Prutsch, Elisabeth Gurnhofer, Tobias Suske, et al.
Leukemia|July 16, 2020
Correction: Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphomaNicole Prutsch, Elisabeth Gurnhofer, Tobias Suske, et al.
Science Translational Medicine|June 28, 2023
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphomaCristina Mastini, Marco Campisi, Enrico Patrucco, et al.
Leukemia|December 24, 2014
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocationF Abate, M Todaro, J-A van der Krogt, et al.
Nature Medicine|June 3, 2020
Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoringAsaf Zviran, Rafael C Schulman, Minita Shah, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Science Translational Medicine|September 27, 2019
CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignanciesHong Qin, Zhenyuan Dong, Xiuli Wang, et al.
Cancer Cell|May 3, 2024
Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomasJaewoo Choi, Michele Ceribelli, James D Phelan, et al.
Blood Cancer Journal|November 10, 2018
Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trialsA Castellino, A Chiappella, B R LaPlant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2011
Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletionM Mian, M Scandurra, E Chigrinova, et al.
Leukemia|August 23, 2018
Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphomaNicole Prutsch, Elisabeth Gurnhofer, Tobias Suske, et al.
Leukemia|July 16, 2020
Correction: Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphomaNicole Prutsch, Elisabeth Gurnhofer, Tobias Suske, et al.
Science Translational Medicine|June 28, 2023
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphomaCristina Mastini, Marco Campisi, Enrico Patrucco, et al.
Leukemia|December 24, 2014
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocationF Abate, M Todaro, J-A van der Krogt, et al.
Nature Medicine|June 3, 2020
Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoringAsaf Zviran, Rafael C Schulman, Minita Shah, et al.
Pageof 10